| INTRODUC TI ON
Toxoplasma gondii is a protozoan parasite with a global distribution. It is an important pathogen of humans and their livestock. In humans, it can cause abortion or a spectrum of clinical diseases dependent on the parasite isolate, the host immune status and whether infection is acquired post-natally or in utero.
1,2 T. gondii infection causes substantial losses due to abortion in livestock (including sheep, goats and pigs) and the ability of livestock to act as reservoir of disease is a public health risk. 3 Limited genetic variability has been recognized in T. gondii strains isolated from Europe and North America for some time. The vast majority of T. gondii isolates characterized to date can be classified as Types I, II and III. 4 Each of these canonical T. gondii lineages has different patterns of virulence as empirically determined in mice and supported by restriction length polymorphisms, isoenzyme analysis, large-scale genome sequencing and transcriptomics. However, more recent analyses of T. gondii isolates from diverse geographical regions, most notably South America, have revealed a greater genetic diversity with at least 15 haplogroups that fall into 6 major clades. 2, [4] [5] [6] [7] The rapidly replicating tachyzoite life cycle stage predominates for around 10-14 days post-infection before differentiating into bradyzoites, which replicate more slowly and form cysts in tissues throughout the body. 8 Tissue cysts are long-lived and are generally not considered responsible for significant disease, although associations with seropositivity and some neuropsychiatric diseases have now been recognized. 9 Infection of immune-competent adults with these canonical strains of T. gondii has been generally considered self-resolving. This is largely due to a robust systemic immune response to T. gondii that controls, but does not eliminate infection. 10 However, tissue cysts are assumed to rupture from time to time and in people with immunodeficiencies disease reactivation occurs, causing neurological and sometimes ocular or systemic disease. 8 T. gondii can also cause congenital disease and abortion, almost exclusively in women infected for the first time during pregnancy. 11 Congenitally infected individuals are also at risk of repeated disease reactivation, mostly evident through ocular and neurological disease, though the reason for this remains to be determined. 12 It is now recognized that certain lineages and
Summary
Toxoplasma gondii is a zoonotic parasite which, depending on the geographical location, can infect between 10% and 90% of humans. Infection during pregnancy may result in congenital toxoplasmosis. The effects on the foetus vary depending on the stage of gestation in which primary maternal infection arises. A large body of research has focused on understanding immune response to toxoplasmosis, although few studies have addressed how it is affected by pregnancy or the pathological consequences of infection at the maternal-foetal interface. There is a lack of knowledge about how maternal immune cells, specifically macrophages, are modulated during infection and the resulting consequences for parasite control and pathology. Herein,
we discuss the potential of T. gondii infection to affect the maternal-foetal interface and the potential of pregnancy to disrupt maternal immunity to T. gondii infection.
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| IMMUNE RE S P ONS E DURING T. GONDII INFEC TI ON
The major findings concerning systemic T. gondii immune response have come from experimental murine models, and much of this has been corroborated through clinical studies and in vitro studies. 8, 14 Challenges exist in extrapolating the data between studies as differences including the mouse strain, parasite strain and life cycle stage used to infect, dose of inoculum and route of infection often vary. Primary T. gondii infection in the first trimester is associated with a high risk of several adverse pregnancy outcomes including abortion, stillbirth and premature birth, but with a low risk of congenital transmission. 11 If pregnancy results in a viable child, T. gondii infection may cause a wide range of clinical manifestations, such as neonatal malformations that are severe enough to ultimately result in blindness, chorioretinitis, mental retardation, heart and brain defects, permanent neurological damage and death. 11 If transmission occurs at later stages of pregnancy, abortion is unlikely, but the risk of congenital infection is increased ( Figure 2 ). 23 Under these F I G U R E 2 Impact of T. gondii infection in pregnancy. Clinical consequences for the foetus and newborn and concomitant alteration to maternal immune mediators at the FMI and hormonal alterations (blue: relative levels during normal pregnancy; red arrows: effect of T. gondii infection on these levels during pregnancy and infection). nd: not described circumstances, infected newborns will often be asymptomatic at birth, but essentially will all develop chorioretinitis later in life. 1, 11, 24 If infection occurs prior to pregnancy, the risk to the unborn child is extremely low, even if the mother is re-exposed to another infection.
| CONG ENITAL TOXOPL A S MOS IS
However, there is a growing body of literature which demonstrates, in a small number of cases, that maternal disease reactivation can occur during pregnancy and sometimes result in adverse effects on the developing foetus 1, 11, 25, 26, 27 . In addition, other cases have been reported in which pregnant women with immune suppression due, for example, to HIV infection have resulted in congenital toxoplasmosis. 28, 29 Furthermore, several studies monitoring females with previously acquired T. gondii infection through pregnancy found maternal disease reactivation at the ocular site. 27, 30 The cysts stages are presumed to be the source of disease reactivation in all of the above scenarios. Altogether, these data suggest that in the vast majority of cases, a previous maternal infection protects against congenital transmission, even when exposed to a heterologous chal- 
| EFFEC T OF T. GONDII INFEC TI ON ON I M PL A NTATI O N
Healthy pregnancy is highly dependent on appropriate immune responses from coitus to post-partum. system with paternal antigens. 33, 35, 36 As the blastocyst undergoes implantation, macrophages are required to clear apoptotic maternal uterine cells. [37] [38] [39] There is now evidence of progressive maternal immune regulation at the maternal-foetal interface comprising the foetus-derived placenta and the decidua. 33, 40 The development of a decidua is dependent on progesterone and is crucial for implantation. 41, 42 The blastocyst breaches the uterine epithelium, an event that is accompanied by inflammation and infiltration of decidual leukocytes, including NK cells, macrophages, dendritic cells and T-cells. 33 The success of implantation is dependent on the expression of a number of cytokines and chemokines including leukaemia inhibitory factor (LIF), IL- The potential for T. gondii to disrupt these early events in pregnancy has scarcely been studied. Nevertheless, in murine models, chronic T. gondii infection has been shown to increase reproductive failure. 47 These alterations have been attributed to tissue cysts of T. gondii in various organs, especially in the brain, potentially causing damage in the hypothalamic-pituitary-gonadal axis and leading to alteration in the female oestrus cycle. 47 However, in other infection models, such as for Trypanosoma cruzi, inhibition of implantation and cell division has also been described. 47 
| EFFEC T OF T. GONDII INFEC TI ON ON THE DE VELOPING PL ACENTA , DECIDUA AND FOE TUS
As pregnancy progresses, there are a number of alterations in the maternal immune system, which facilitate fetoplacental development and prevent foetal rejection. 32 Successful healthy pregnancy is highly dependent on specific regulation and balance of maternal immune responses within the decidua and placenta. This immune regulation enables growth and provides protection of the semi-allogeneic foetus, expressing paternal major histocompatibility antigens from maternal immune rejection. 51, 52 Dysfunction of this immune regulation by extrinsic factors, as in the case of infection, compromises pregnancy maintenance leading to adverse gestational outcomes. The immune response within the placenta provides protection from infection and contributes to maternal tissue remodelling, which is fundamental for foetus development. 1, 57 Human and experimental animal models have shown that trophoblasts are a component of the innate immune system, since they recognize pathogens, produce chemokines and cytokines, which influence the differentiation and migration of macrophages, NK, Treg and DCs at the decidua. [58] [59] [60] Trophoblasts are responsible for the production of a variety of anti-inflammatory mediators, including TGF-β, IL-10 and Fas ligand. 61 However, in some situations, trophoblasts may also initiate signals that promote foetal rejection. 62, 63 For example, studies have demonstrated that activation of TLR3 with specific antibodies. 66 Thus, IFN-γ was not able to control T. gondii proliferation in Bewo cells, contrary to expected, suggesting that this cytokine has different activities at the maternal-foetal interface, depending on other host factors. 66 Recently, ex-vivo experiments, using primary human trophoblasts isolated from placentas of both the second and third trimesters, have shown that syncytiotrophoblast cells are able to restrict
T. gondii attachment and intracellular parasite replication in an IFN-
γ-independent manner. 67 The T regulatory chemoattractant CCL22 expression has been associated with miscarriage, 68 and levels of this ligand were increased in primary human placental cells isolated from full-term placentas in response to T. gondii infection. 67 It has also been shown that earlier in human pregnancy, using mid-gestation chorionic villous explants, trophoblasts was also able to restrict T. gondii attachment and increase CCL22 production. 67 Increased trophoblast apoptosis and necrosis occurring after T. gondii infection is dependent on inflammatory cytokines, such as IFNγ, which can be a factor in determining pregnancy outcomes in women infected by this parasite. 69 In contrast, IL-10 is able to reduce T. gondii-infected trophoblast apoptosis levels. 69 If trophoblast invasion is excessive, which occurs during a T. gondii infection, IFN-γ has a dual function, thereby limiting parasite replication and promoting its removal. 40, 66 Adhesion of infected monocytes to trophoblasts could also promote placental and foetal infection. However, trophoblasts are able to modulate monocyte activity controlling T. gondii infection, thus promoting pregnancy maintenance. 70 Overall, the interaction between trophoblast cells and maternal-foetal immune cells, specifically macrophages, is likely to determine T. gondii survival and putative vertical transmission. 72, 73 Depending on the decidua environment, DSC can contribute to a successful pregnancy or miscarriage. 74, 75 T. gondii tropism is not clearly understood, although the decidua/trophoblasts interface is highly vulnerable to infection after parasite dissemination through maternal leukocytes. 54 As yet, there is no description regarding the interplay between DSC and T. gondii infection.
| DECIDUAL IMMUNE CELL S AND T. GONDII INFEC TI ON
The decidua is a highly dynamic immunological tissue composed of different maternal immune cell types and is also modulated by placentalderived factors. 51, 76 Recently, murine studies have suggested an important role for CCR5 and RANTES in abortion caused by T. gondii infection. 77 In fact, it is suggested that embryo loss results from alteration of decidual and trophoblastic function, induced by recruitment of macrophages, DCs and T-cells in response to increased expression levels of CCR5 and RANTES, in implantation units from T. gondii-infected mice. 77 Quantitative proteomic analysis of T. 
| Decidual macrophages during T. gondii infection
Decidual macrophages (dMϕ) constitute 20% of the decidual leukocyte population and represent the second most abundant immune cell-type population in decidua. 37, 76 dMϕ are recruited to the maternal-foetal interface by stromal and trophoblast cells, where they have specialized functions, such as decidual homeostasis, placental development and tolerance to the semi-allogeneic trophoblast. They also form a major line of defence against invading pathogens in the decidua and thus protect the foetus from infection. 37, 84, 85 In vitro studies have shown that dMϕ differentiation and polarization are regulated by factors produced by trophoblasts such as IL-10, suppressing IFNγ-induced Stat1 activation. 86 During early gestation, dMϕ are also major producers of IL-10 and are able to suppress and regulate the decidua immune response. 37, 38 dMϕ can decrease the cytolytic activity of dNK cells against invading trophoblasts. These leukocytes also play a role in the induction and expansion of Treg cells, contributing to the maintenance and support of uterine tissue homeostasis and remodelling. 37, 38, 87 dMϕ are able to recognize, phagocytose and eliminate pathogens. In addition, they also remove apoptotic cells and cellular debris and, therefore, promote normal foetal development and acceptance, preventing tissue damage and foetal rejection. 37, 38, 87, 88 T. gondii infection of human trophoblasts modulates trophoblastmacrophage crosstalk, in order to favour its establishment in the host cell. 71 The polarization of dMϕ is modulated by T. gondii infection, but it is still unclear at present how this occurs during human pregnancy. 85 Human and animal studies support the occurrence of both classical and alternative activation in macrophages responding to T. gondii. 89 Macrophages have a variety of activation states, being able to adapt their functions to cytokine environmental 
| Decidual DCs during T. gondii infection
DCs are antigen-presenting cells priming T-cell in all adjectival occurrences, responses, but dDCs fail to initiate immunogenic T-cell responses to placental antigens, thus contributing to maternalfoetal tolerance. 38, 103 Despite the fewer number of human DCs at the decidua, they play determinant roles in normal and pathological pregnancies. 104, 105 In addition, DCs are important for maternalfoetal tolerance and are also involved in angiogenic responses at the maternal-foetal interface. 105 In normal human decidua, both immature myeloid-identifiable by their expression of DC-SIGN (CD209)-and mature myeloid DCs coexist. 105 In early human pregnancy, the presence of DC-SIGN+ cells and dNK clusters indicates that the interconnection between these cell subsets is essential in pregnancy maintenance. 106 In fact, dNK cells induce apoptosis in DC-SIGN+ cells, constituting a mechanism of maternal-foetal tolerance. 106 Other models of infection, namely with Coxiella burnetii and Brucella abortus, revealed that myeloid dDCs are unable to mature in response to bacterial ligands, such as peptidoglycan or LPS, or to produce inflammatory cytokines. This would prevent development of effective immunity and favour pathogen multiplication. 107 However, contrary to these observations during bacterial infections, in vitro studies have shown that T. gondii-infected human dDCs produced IL-12 which increased the cytotoxicity of dNK cells as determined by increased expression of NKG2D and production of IFN-γ. The presence of increased IL-12 and IFN-γ levels would favour Th1 cells and suppress Th2 cells and thus contribute to disruption of pregnancy. 48 
| Decidual T-cells and T. gondii infection
The relative balance of lymphoid cells, such as Th1, Th2 and Treg cells, present at the decidua coordinates macrophage polarization and is vital for successful pregnancy. 108 In the past, it was accepted that maternal-foetal immunological balance could be disturbed by In this study, it has been shown that P4 treatment of murine macrophages selectively reduces transcription of mrc1 (coding for mannose receptor), but increases transcription of ym1, demonstrating plasticity in alternative macrophage activation with potential significant consequences for pregnancy. 92 In addition, P4 contributes to a local Th2-associated cytokines production by murine fetoplacental tissues and recently it has been demonstrated to negatively regulate the differentiation of Th cells into Th1 and Th17. 92, 120 Therefore, it is possible that during T. gondii infection, low levels of P4 may be implicated in altered macrophage polarization and T-cell responses, negatively affecting pregnancy. Moreover, during pregnancy, progesterone is able to induce the secretion of progesterone-induced blocking factor (PIBF) by progesterone-receptor-positive lymphocytes. 121 PIBF is able to modulate Th1/Th2 balance and contribute to the enhanced Th2 profile noted during pregnancy, characterized by increased production of IL-4 and IL-10. 121 Notably, PIBF can also downregulate NK cytotoxicity favouring gestation progression 
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